Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The market has given TLT a risk reward price

<< Previous

Bullboard Posts

Next >>

Comment by CAinPlapon Sep 06, 2023 5:11pm

185 Views

Post# 35622772

RE:RE:The market has given TLT a risk reward price

Because of the PP in progress, there is more selling preasure from those wanting to participate is my guess. What i find more interesting is the warrants being sold down. Are there those willing to take a hit on the old warrants to get newer ones?

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments